Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Resche-Rigon

Showing results (151-160 of 198) with videos related to

Pageof 20
Sort By:
Critical Care (London, England)|May 20, 2020
Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter studyAdrien Mirouse, Antoine Parrot, Vincent Audigier, et al.
Contemporary Clinical Trials|June 6, 2021
Facilitating communication for critically ill patients and their family members: Study protocol for two randomized trials implemented in the U.S. and FranceJ Randall Curtis, Nancy Kentish-Barnes, Lyndia C Brumback, et al.
EMBO Molecular Medicine|March 28, 2025
Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanomaIkuan Sam, Nadine Benhamouda, Lucie Biard, et al.
Arthritis Care & Research|November 14, 2025
Response to allopurinol and febuxostat according to the fractional excretion of urate in men with goutPascal Richette, Anouk Walter-Petrich, Quang Dinh Nguyen, et al.
Critical Care Medicine|October 5, 2010
Functional outcome after convulsive status epilepticusStéphane Legriel, Elie Azoulay, Matthieu Resche-Rigon, et al.
Cancer Immunology, Immunotherapy : CII|May 30, 2018
Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective studyMarie-Léa Gauci, Philippe Boudou, Barouyr Baroudjian, et al.
European Journal of Heart Failure|November 29, 2012
Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA studyDamien Logeart, Richard Isnard, Matthieu Resche-Rigon, et al.
Annals of Intensive Care|October 27, 2016
Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) studyAdrien Contejean, Virginie Lemiale, Matthieu Resche-Rigon, et al.
The Lancet. Rheumatology|December 20, 2024
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 studyDominique Farge, Lucie Biard, Ben Weil, et al.
ERJ Open Research|April 9, 2026
Efficacy and safety of danazol for pulmonary fibrosis or bone-marrow failure associated with telomere-related gene mutationFlore Sicre de Fontbrune, Stéphane Jouneau, Vincent Cottin, et al.
Pageof 20

Showing results (151-160 of 198) with videos related to

Sort By:
Pageof 20
Critical Care (London, England)|May 20, 2020
Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter studyAdrien Mirouse, Antoine Parrot, Vincent Audigier, et al.
Contemporary Clinical Trials|June 6, 2021
Facilitating communication for critically ill patients and their family members: Study protocol for two randomized trials implemented in the U.S. and FranceJ Randall Curtis, Nancy Kentish-Barnes, Lyndia C Brumback, et al.
EMBO Molecular Medicine|March 28, 2025
Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanomaIkuan Sam, Nadine Benhamouda, Lucie Biard, et al.
Arthritis Care & Research|November 14, 2025
Response to allopurinol and febuxostat according to the fractional excretion of urate in men with goutPascal Richette, Anouk Walter-Petrich, Quang Dinh Nguyen, et al.
Critical Care Medicine|October 5, 2010
Functional outcome after convulsive status epilepticusStéphane Legriel, Elie Azoulay, Matthieu Resche-Rigon, et al.
Cancer Immunology, Immunotherapy : CII|May 30, 2018
Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective studyMarie-Léa Gauci, Philippe Boudou, Barouyr Baroudjian, et al.
European Journal of Heart Failure|November 29, 2012
Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA studyDamien Logeart, Richard Isnard, Matthieu Resche-Rigon, et al.
Annals of Intensive Care|October 27, 2016
Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) studyAdrien Contejean, Virginie Lemiale, Matthieu Resche-Rigon, et al.
The Lancet. Rheumatology|December 20, 2024
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 studyDominique Farge, Lucie Biard, Ben Weil, et al.
ERJ Open Research|April 9, 2026
Efficacy and safety of danazol for pulmonary fibrosis or bone-marrow failure associated with telomere-related gene mutationFlore Sicre de Fontbrune, Stéphane Jouneau, Vincent Cottin, et al.
Pageof 20